Walvax Biotechnology Co., Ltd. (300142.SZ)
CNY 10.79
(-0.09%)
CNY 10.79
(-0.09%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 419.39 Million CNY | -42.44% |
| 2022 | 728.65 Million CNY | 21.17% |
| 2021 | 601.35 Million CNY | -40.06% |
| 2020 | 1 Billion CNY | 416.75% |
| 2019 | 194.13 Million CNY | -81.44% |
| 2018 | 1.04 Billion CNY | 294.77% |
| 2017 | -537.13 Million CNY | -862.34% |
| 2016 | 70.45 Million CNY | 108.38% |
| 2015 | -840.89 Million CNY | -686.3% |
| 2014 | 143.42 Million CNY | 199.47% |
| 2013 | 47.89 Million CNY | -79.43% |
| 2012 | 232.8 Million CNY | 12.17% |
| 2011 | 207.53 Million CNY | 34.4% |
| 2010 | 154.41 Million CNY | 102.3% |
| 2009 | 76.33 Million CNY | 119.98% |
| 2008 | 34.7 Million CNY | 367.37% |
| 2007 | 7.42 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 156.43 Million CNY | 1007.29% |
| 2024 Q3 | 85.79 Million CNY | -45.15% |
| 2024 Q1 | 14.12 Million CNY | 110.54% |
| 2023 Q2 | 283.24 Million CNY | 64.69% |
| 2023 Q1 | 171.99 Million CNY | -12.81% |
| 2023 Q3 | 98.13 Million CNY | -65.35% |
| 2023 Q4 | -133.98 Million CNY | -236.53% |
| 2023 FY | 419.39 Million CNY | -42.44% |
| 2022 FY | 728.65 Million CNY | 21.17% |
| 2022 Q1 | 66.74 Million CNY | 5.32% |
| 2022 Q3 | 186.7 Million CNY | -51.17% |
| 2022 Q2 | 382.38 Million CNY | 472.87% |
| 2022 Q4 | 197.25 Million CNY | 5.65% |
| 2021 Q4 | 63.37 Million CNY | 40.29% |
| 2021 Q1 | 32.15 Million CNY | -94.34% |
| 2021 Q2 | 287.03 Million CNY | 792.56% |
| 2021 Q3 | 45.17 Million CNY | -84.26% |
| 2021 FY | 601.35 Million CNY | -40.06% |
| 2020 Q1 | -18.11 Million CNY | -183.85% |
| 2020 Q2 | 79.6 Million CNY | 539.4% |
| 2020 FY | 1 Billion CNY | 416.75% |
| 2020 Q3 | 373.98 Million CNY | 369.78% |
| 2020 Q4 | 567.71 Million CNY | 51.8% |
| 2019 Q2 | 46.2 Million CNY | 19.28% |
| 2019 FY | 194.13 Million CNY | -81.44% |
| 2019 Q1 | 38.73 Million CNY | -95.94% |
| 2019 Q3 | 35.43 Million CNY | -23.31% |
| 2019 Q4 | 21.6 Million CNY | -39.02% |
| 2018 Q1 | 23.75 Million CNY | 104.77% |
| 2018 FY | 1.04 Billion CNY | 294.77% |
| 2018 Q3 | 17.96 Million CNY | -63.64% |
| 2018 Q4 | 955.08 Million CNY | 5217.73% |
| 2018 Q2 | 49.4 Million CNY | 107.94% |
| 2017 Q3 | 3.7 Million CNY | 126.99% |
| 2017 FY | -537.13 Million CNY | -862.34% |
| 2017 Q1 | -29.29 Million CNY | -109.64% |
| 2017 Q2 | -13.71 Million CNY | 53.18% |
| 2017 Q4 | -497.82 Million CNY | -13547.66% |
| 2016 Q3 | -71.7 Million CNY | 40.17% |
| 2016 FY | 70.45 Million CNY | 108.38% |
| 2016 Q1 | -42.05 Million CNY | 94.23% |
| 2016 Q4 | 304.06 Million CNY | 524.03% |
| 2016 Q2 | -119.84 Million CNY | -184.98% |
| 2015 Q2 | -18.86 Million CNY | 60.91% |
| 2015 FY | -840.89 Million CNY | -686.3% |
| 2015 Q4 | -729.22 Million CNY | -1536.87% |
| 2015 Q3 | -44.54 Million CNY | -136.15% |
| 2015 Q1 | -48.25 Million CNY | -116.45% |
| 2014 Q1 | -51.36 Million CNY | -559.23% |
| 2014 Q2 | -10.49 Million CNY | 79.57% |
| 2014 Q3 | -88.08 Million CNY | -739.46% |
| 2014 Q4 | 293.37 Million CNY | 433.05% |
| 2014 FY | 143.42 Million CNY | 199.47% |
| 2013 Q1 | 25.85 Million CNY | -66.6% |
| 2013 Q2 | 51.02 Million CNY | 97.32% |
| 2013 Q3 | -40.17 Million CNY | -178.74% |
| 2013 Q4 | 11.18 Million CNY | 127.84% |
| 2013 FY | 47.89 Million CNY | -79.43% |
| 2012 Q2 | 84.43 Million CNY | 261.43% |
| 2012 Q1 | 23.36 Million CNY | -67.86% |
| 2012 FY | 232.8 Million CNY | 12.17% |
| 2012 Q4 | 77.42 Million CNY | 62.72% |
| 2012 Q3 | 47.58 Million CNY | -43.65% |
| 2011 Q3 | 51.01 Million CNY | -20.14% |
| 2011 Q4 | 72.67 Million CNY | 42.47% |
| 2011 Q1 | 19.96 Million CNY | -61.86% |
| 2011 FY | 207.53 Million CNY | 34.4% |
| 2011 Q2 | 63.87 Million CNY | 219.89% |
| 2010 Q2 | 46.9 Million CNY | 385.55% |
| 2010 FY | 154.41 Million CNY | 102.3% |
| 2010 Q4 | 52.35 Million CNY | 15.07% |
| 2010 Q3 | 45.49 Million CNY | -2.99% |
| 2010 Q1 | 9.65 Million CNY | 0.0% |
| 2009 FY | 76.33 Million CNY | 119.98% |
| 2008 FY | 34.7 Million CNY | 367.37% |
| 2007 FY | 7.42 Million CNY | 0.0% |